Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - Euronext Paris - Matif - FR0014003711 - Common Stock - Currency: EUR

3.7  0 (0%)

Fundamental Rating

3

Taking everything into account, ALBIZ scores 3 out of 10 in our fundamental rating. ALBIZ was compared to 61 industry peers in the Media industry. While ALBIZ seems to be doing ok healthwise, there are quite some concerns on its profitability. ALBIZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALBIZ had negative earnings in the past year.
ALBIZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALBIZ reported negative net income in multiple years.
ALBIZ had a positive operating cash flow in 4 of the past 5 years.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

With a Return On Assets value of -4.69%, ALBIZ is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
With a Return On Equity value of -21.64%, ALBIZ is not doing good in the industry: 75.38% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Gross Margin of ALBIZ (13.37%) is worse than 86.15% of its industry peers.
In the last couple of years the Gross Margin of ALBIZ has declined.
The Profit Margin and Operating Margin are not available for ALBIZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

ALBIZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBIZ has more shares outstanding
The number of shares outstanding for ALBIZ has been increased compared to 5 years ago.
The debt/assets ratio for ALBIZ has been reduced compared to a year ago.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.81 indicates that ALBIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALBIZ's Altman-Z score of 2.81 is amongst the best of the industry. ALBIZ outperforms 90.77% of its industry peers.
A Debt/Equity ratio of 1.70 is on the high side and indicates that ALBIZ has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.70, ALBIZ is doing worse than 75.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 2.81
ROIC/WACCN/A
WACC5.9%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.17 indicates that ALBIZ has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.17, ALBIZ belongs to the best of the industry, outperforming 95.38% of the companies in the same industry.
A Quick Ratio of 1.90 indicates that ALBIZ should not have too much problems paying its short term obligations.
ALBIZ's Quick ratio of 1.90 is amongst the best of the industry. ALBIZ outperforms 90.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.9
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

ALBIZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2780.72%.
ALBIZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.46%.
The Revenue has been growing by 67.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%

3.2 Future

Based on estimates for the next years, ALBIZ will show a very strong growth in Earnings Per Share. The EPS will grow by 292.43% on average per year.
Based on estimates for the next years, ALBIZ will show a small growth in Revenue. The Revenue will grow by 6.63% on average per year.
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.1 0.2 0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALBIZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 14.09, ALBIZ is valued correctly.
ALBIZ's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.67. ALBIZ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.09
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ALBIZ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALBIZ is more expensive than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.19
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALBIZ's earnings are expected to grow with 292.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y292.43%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBIZ SA

EPA:ALBIZ (7/25/2025, 7:00:00 PM)

3.7

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap21.72M
Analysts87.27
Price Target8.3 (124.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.09
P/S 0.17
P/FCF N/A
P/OCF 20.81
P/B 1.82
P/tB N/A
EV/EBITDA 17.19
EPS(TTM)-0.44
EYN/A
EPS(NY)0.26
Fwd EY7.1%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.18
OCFY4.81%
SpS21.44
BVpS2.04
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.37%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 9.61
Cap/Depr 119.21%
Cap/Sales 2.2%
Interest Coverage N/A
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.9
Altman-Z 2.81
F-Score4
WACC5.9%
ROIC/WACCN/A
Cap/Depr(3y)85.83%
Cap/Depr(5y)92.26%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%
EBIT growth 1Y-120.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.24%
EBIT Next 3Y91.94%
EBIT Next 5Y57.12%
FCF growth 1Y-434.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.6%
OCF growth 3YN/A
OCF growth 5Y4.44%